Cargando…

Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan

BACKGROUND: To evaluate the impact of the 2002 Women's Health Initiative (WHI) study results on the prescription of menopausal hormone therapy (MHT) to treat menopause-related symptoms in Taiwan. METHODS: This retrospective study participant data collected from women interviewed in 2001 Taiwan&...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Weng-Foung, Tsai, Yi-Wen, Hsiao, Fei-Yuan, Liu, Wen-Chun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871579/
https://www.ncbi.nlm.nih.gov/pubmed/17439639
http://dx.doi.org/10.1186/1471-2458-7-56
_version_ 1782133436642754560
author Huang, Weng-Foung
Tsai, Yi-Wen
Hsiao, Fei-Yuan
Liu, Wen-Chun
author_facet Huang, Weng-Foung
Tsai, Yi-Wen
Hsiao, Fei-Yuan
Liu, Wen-Chun
author_sort Huang, Weng-Foung
collection PubMed
description BACKGROUND: To evaluate the impact of the 2002 Women's Health Initiative (WHI) study results on the prescription of menopausal hormone therapy (MHT) to treat menopause-related symptoms in Taiwan. METHODS: This retrospective study participant data collected from women interviewed in 2001 Taiwan's National Health Interview Survey (NHIS) and the National Health Insurance (NHI) outpatient claims for women being treated for menopause-related symptoms. We compared prescriptions made for MHI to women seeking outpatient treatment for menopause-related symptoms before and after the publication of the 2002 WHI to study its effect of prescription behavior in Taiwan. There was one dichotomous outcome variable, which was whether MHT was prescribed or not in an outpatient visit to treat menopause-related symptoms. RESULTS: Our study included 504 women 45 years old or above whose outpatient visits for menopause-related symptoms were covered by National Health Insurance in 2002. In total, these 504 women made 2549 outpatient visits to be treated for these symptoms. The proportion of outpatient visits in which MHT was prescribed dropped from 83.0% (n = 1,155) before WHI to 73.0% (n = 844) after WHI. We found a decrease in likelihood that women would be prescribed MHT for menopause-related symptoms after the release of the WHI report (OR = 0.36, 95%CI = 0.25 to 0.52, p < 0.05). Gynecologists and obstetricians are more likely to prescribe MHT than physicians with other medical specialties (5.34; 95%CI = 3.45 to 8.26, p < 0.05). Women with college level educations or higher became less likely to be prescribed MHT (Model 2; OR 0.30; 95% CI 0.11–0.83), and academic medical centers became less likely to prescribe MHT than other medical care institutions (Model 3; OR 0.15; 95% CI 0.34–0.63). CONCLUSION: The WHI report caused a substantial decline in the use of MHT to treat menopause-related symptoms in Taiwan. It was found to exert most of its influence in patients with higher educations, physicians with specialties other than gynecologists and obstetricians, and academic medical centers.
format Text
id pubmed-1871579
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18715792007-05-17 Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan Huang, Weng-Foung Tsai, Yi-Wen Hsiao, Fei-Yuan Liu, Wen-Chun BMC Public Health Research Article BACKGROUND: To evaluate the impact of the 2002 Women's Health Initiative (WHI) study results on the prescription of menopausal hormone therapy (MHT) to treat menopause-related symptoms in Taiwan. METHODS: This retrospective study participant data collected from women interviewed in 2001 Taiwan's National Health Interview Survey (NHIS) and the National Health Insurance (NHI) outpatient claims for women being treated for menopause-related symptoms. We compared prescriptions made for MHI to women seeking outpatient treatment for menopause-related symptoms before and after the publication of the 2002 WHI to study its effect of prescription behavior in Taiwan. There was one dichotomous outcome variable, which was whether MHT was prescribed or not in an outpatient visit to treat menopause-related symptoms. RESULTS: Our study included 504 women 45 years old or above whose outpatient visits for menopause-related symptoms were covered by National Health Insurance in 2002. In total, these 504 women made 2549 outpatient visits to be treated for these symptoms. The proportion of outpatient visits in which MHT was prescribed dropped from 83.0% (n = 1,155) before WHI to 73.0% (n = 844) after WHI. We found a decrease in likelihood that women would be prescribed MHT for menopause-related symptoms after the release of the WHI report (OR = 0.36, 95%CI = 0.25 to 0.52, p < 0.05). Gynecologists and obstetricians are more likely to prescribe MHT than physicians with other medical specialties (5.34; 95%CI = 3.45 to 8.26, p < 0.05). Women with college level educations or higher became less likely to be prescribed MHT (Model 2; OR 0.30; 95% CI 0.11–0.83), and academic medical centers became less likely to prescribe MHT than other medical care institutions (Model 3; OR 0.15; 95% CI 0.34–0.63). CONCLUSION: The WHI report caused a substantial decline in the use of MHT to treat menopause-related symptoms in Taiwan. It was found to exert most of its influence in patients with higher educations, physicians with specialties other than gynecologists and obstetricians, and academic medical centers. BioMed Central 2007-04-17 /pmc/articles/PMC1871579/ /pubmed/17439639 http://dx.doi.org/10.1186/1471-2458-7-56 Text en Copyright © 2007 Huang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Huang, Weng-Foung
Tsai, Yi-Wen
Hsiao, Fei-Yuan
Liu, Wen-Chun
Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
title Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
title_full Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
title_fullStr Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
title_full_unstemmed Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
title_short Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
title_sort changes of the prescription of hormone therapy in menopausal women: an observational study in taiwan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871579/
https://www.ncbi.nlm.nih.gov/pubmed/17439639
http://dx.doi.org/10.1186/1471-2458-7-56
work_keys_str_mv AT huangwengfoung changesoftheprescriptionofhormonetherapyinmenopausalwomenanobservationalstudyintaiwan
AT tsaiyiwen changesoftheprescriptionofhormonetherapyinmenopausalwomenanobservationalstudyintaiwan
AT hsiaofeiyuan changesoftheprescriptionofhormonetherapyinmenopausalwomenanobservationalstudyintaiwan
AT liuwenchun changesoftheprescriptionofhormonetherapyinmenopausalwomenanobservationalstudyintaiwan